PTPRC and synovial sarcoma: Our results showed a B cell dominant role in the pathological mechanism of hMSCs for the recovery of DE parameters in the SS mouse model, with attenuated infiltration of inflammatory cells in the lacrimal glands, most prominently the B cell marker, B220, but not the T cell marker, CD3.